Decitabine
Advanced Fallopian Tube Carcinoma
Roswell Park Cancer InstituteSmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 89/ 100
Competitive context
72 Active assets in the Advanced Fallopian Tube Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Women's Hospital School Of Medicine Zhejiang University | Phase 3 | BBB |
CIS-DIAMMINEDICHLOROPLATINUM II Mayo Clinic | Phase 3 | BB |
TAMOXIFEN Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Phase 3 | BB |
Cyclophosphamide Mayo Clinic | Phase 2 | BB |
Pembrolizumab Roswell Park Cancer Institute | Phase 2 | BB |
View all 50 →
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →